PHONE: 03 9700 7666
Consultant Rheumatologist: Monash Medical Centre
Consultant Rheumatologist: Peninsula Health
Academic Teaching Associate: Monash University
Adjunct Research Associate: Centre for Inflammatory Disease – Monash Health
Dr Daniel Boulos (MBBS (Hons), FRACP) is a consultant Rheumatologist and General Medicine physician with a public appointment at Monash Health and an academic teaching affiliation with Monash University. Dr Boulos completed his medical degree at Monash University, graduating with honours, before completing his specialty rheumatology training at the Royal Melbourne Hospital and Monash Medical Centre.
Dr Boulos has a keen interest in research, having published several papers focused on leveraging ‘big-data’ to identify underappreciated markers of disease activity and severity. Dr Boulos has been invited to present at both national and international conferences including the European League against Rheumatism and the American College of Rheumatology.
Dr Boulos’ main interests are around the inflammatory arthritis conditions, including seronegative arthropathies and musculoskeletal disorders. In particular, he has an interest in the interplay of the biopsychosocial mechanisms of illness and their influence on disease presentation. Outside of work, Dr Boulos enjoys cooking and horse riding.
Boulos D, Proudman S, Metcalf R, McWilliams L, Hall C, Wicks I. “The Neutrophil-Lymphocyte Ratio in early Rheumatoid Arthritis and its Ability to Predict Subsequent Failure of Triple Therapy.” Semin Arthritis Rheum 2019; 49(3):373-6
Boulos D, Ngian G, Rajadurai A, Elford K, Stevens W, Proudman S, Owen C, Roddy J, Nikpour M, Youssef P, Hill C, Sahhar J. “Long-term Efficacy and Tolerability of Mycophenolate Mofetil Therapy in Diffuse Scleroderma Skin Disease.” Int J Rheum Dis 2017; 20(4):481-8
Boulos D, Koelmeyer R, Morand E, Hoi A. "Cardiovascular Risk Profiles in a Lupus Cohort: what do different calculators tells us?" Lupus Sci Med 2017;4(1):e000212
Antony A, Kandane-Rathnayake RK, Ko T, Boulos D, Hoi A, Jolly M, Morand E. “Validation of the Lupus Impact Tracker in an Australian Patient Cohort.” Lupus 2016;26(1):98-105
Boulos D, Morand E, Foo M, Trivedi J, Lai R, Huntersmitth R, Zhang K, Stark C, Le S. “Acceptability of Opt-out Consent in a hospital patient population”. IMJ 2018;48(1):84-7
Boulos D, Shehabi Y, Moggahddas, Birrel M, Choy A, Giang V, Nguyen J, Hall T, Le S. “Predictive Value of Quick Sepsis-Related Organ Failure Scores following sepsis-related Medical Emergency Team calls: a retrospective cohort study.” AIC 2017;45(6):688-94
Rofu A, Boulos D, Hanna M, Jackson B, Coutsouvelis J, Mak V, Rofu N, Egorova T, Uruthirasigna N, Bhatia K, Kirsa S. “Validation of a risk stratification tool for a Hospital Outreach Medication Review (HOMR) program.” Res Social Adm Pharm 2019; 15(9):1133-7.
Blecher G, Meek R, Egerton-Warburton, Mccahy P, Bach C, Boulos D. “Predictors for Urologic Intervention and Alternate Diagnoses in People Having Computed Tomography Urography for Suspected Renal Colic.” Emerg Med Australas. 2016;28(1):56-61.
Dr Daniel Boulos
(MBBS (Hons), FRACP)